Two Sigma Advisers LP cut its position in Raymond James (NYSE:RJF - Free Report) by 27.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 201,000 shares of the financial services provider's stock after selling 77,500 shares during the period. Two Sigma Advisers LP owned approximately 0.10% of Raymond James worth $31,221,000 at the end of the most recent quarter.
Several other institutional investors have also recently modified their holdings of RJF. Barclays PLC increased its holdings in Raymond James by 33.5% in the 3rd quarter. Barclays PLC now owns 847,108 shares of the financial services provider's stock worth $103,738,000 after buying an additional 212,697 shares during the period. JPMorgan Chase & Co. boosted its holdings in shares of Raymond James by 12.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 4,544,610 shares of the financial services provider's stock valued at $556,533,000 after acquiring an additional 488,245 shares during the last quarter. Wealthcare Advisory Partners LLC purchased a new stake in shares of Raymond James in the 4th quarter valued at $378,000. HB Wealth Management LLC acquired a new stake in shares of Raymond James in the fourth quarter worth $223,000. Finally, Ballentine Partners LLC raised its holdings in shares of Raymond James by 5.9% during the fourth quarter. Ballentine Partners LLC now owns 2,284 shares of the financial services provider's stock worth $355,000 after purchasing an additional 128 shares during the last quarter. 83.83% of the stock is currently owned by hedge funds and other institutional investors.
Raymond James Price Performance
Shares of NYSE:RJF traded down $0.95 during midday trading on Monday, hitting $145.52. The company had a trading volume of 639,571 shares, compared to its average volume of 1,306,564. Raymond James has a twelve month low of $104.24 and a twelve month high of $174.32. The stock has a market cap of $29.36 billion, a price-to-earnings ratio of 14.20, a price-to-earnings-growth ratio of 0.90 and a beta of 1.02. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.03 and a quick ratio of 1.01. The business's 50-day simple moving average is $139.99 and its 200-day simple moving average is $152.45.
Raymond James (NYSE:RJF - Get Free Report) last posted its quarterly earnings results on Wednesday, April 23rd. The financial services provider reported $2.42 EPS for the quarter, missing the consensus estimate of $2.44 by ($0.02). The company had revenue of $3.40 billion for the quarter, compared to analysts' expectations of $3.46 billion. Raymond James had a return on equity of 19.71% and a net margin of 14.06%. The firm's revenue was up 9.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.31 EPS. On average, research analysts predict that Raymond James will post 11.17 earnings per share for the current year.
Raymond James Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.37%. The ex-dividend date of this dividend is Tuesday, July 1st. Raymond James's dividend payout ratio (DPR) is presently 19.25%.
Wall Street Analyst Weigh In
RJF has been the topic of several recent research reports. JPMorgan Chase & Co. lowered their price target on shares of Raymond James from $149.00 to $143.00 and set a "neutral" rating on the stock in a report on Thursday, April 24th. Wall Street Zen downgraded Raymond James from a "buy" rating to a "hold" rating in a research note on Monday, February 10th. The Goldman Sachs Group reduced their price target on Raymond James from $198.00 to $173.00 and set a "buy" rating for the company in a research report on Thursday, April 3rd. Wells Fargo & Company decreased their price target on Raymond James from $176.00 to $143.00 and set an "equal weight" rating for the company in a report on Tuesday, April 8th. Finally, Keefe, Bruyette & Woods lifted their target price on shares of Raymond James from $170.00 to $177.00 and gave the company a "market perform" rating in a report on Thursday, January 30th. Eleven investment analysts have rated the stock with a hold rating, two have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and an average price target of $153.82.
View Our Latest Research Report on RJF
Insider Buying and Selling at Raymond James
In other news, insider James E. Bunn sold 3,650 shares of Raymond James stock in a transaction that occurred on Monday, April 28th. The shares were sold at an average price of $136.49, for a total transaction of $498,188.50. Following the sale, the insider now owns 78,227 shares of the company's stock, valued at approximately $10,677,203.23. The trade was a 4.46% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.54% of the stock is currently owned by company insiders.
About Raymond James
(
Free Report)
Raymond James Financial, Inc, a financial holding company, through its subsidiaries, engages in the underwriting, distribution, trading, and brokerage of equity and debt securities, and the sale of mutual funds and other investment products in the United States, Canada, Europe, and internationally. The company operates through Private Client Group, Capital Markets, Asset Management, RJ Bank, and Other segments.
Recommended Stories

Before you consider Raymond James, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Raymond James wasn't on the list.
While Raymond James currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.